-
2
-
-
38849133610
-
-
Mulvihill M.J., Ji Q.-S., Coate H.R., Cooke A., Dong H., Feng L., Foreman K., Rosenfeld-Franklin M., Honda A., Mak G., Mulvihill K.M., Nigro A.I., O'Connor M., Pirrit C., Steinig A.G., Siu K., Stolz K.M., Sun Y., Tavares P.A.R., Yao Y., and Gibson N.W. Bioorg. Med. Chem. 16 (2008) 1359
-
(2008)
Bioorg. Med. Chem.
, vol.16
, pp. 1359
-
-
Mulvihill, M.J.1
Ji, Q.-S.2
Coate, H.R.3
Cooke, A.4
Dong, H.5
Feng, L.6
Foreman, K.7
Rosenfeld-Franklin, M.8
Honda, A.9
Mak, G.10
Mulvihill, K.M.11
Nigro, A.I.12
O'Connor, M.13
Pirrit, C.14
Steinig, A.G.15
Siu, K.16
Stolz, K.M.17
Sun, Y.18
Tavares, P.A.R.19
Yao, Y.20
Gibson, N.W.21
more..
-
3
-
-
0034684787
-
-
Altmann K.-H., Bold G., Caravatti G., Flörsheimer A., Guagnano V., and Wartmann M. Bioorg. Med. Chem. Lett. 10 (2007) 2765
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 2765
-
-
Altmann, K.-H.1
Bold, G.2
Caravatti, G.3
Flörsheimer, A.4
Guagnano, V.5
Wartmann, M.6
-
4
-
-
33747051802
-
-
Nomura T., Iwaki T., Narukawa Y., Uotani K., Hori T., and Miwa H. Bioorg. Med. Chem. 14 (2008) 3697
-
(2008)
Bioorg. Med. Chem.
, vol.14
, pp. 3697
-
-
Nomura, T.1
Iwaki, T.2
Narukawa, Y.3
Uotani, K.4
Hori, T.5
Miwa, H.6
-
5
-
-
0034687224
-
-
For example, see: Additional examples are found in Refs. 1,2
-
For example, see:. Plobeck N., Delorme D., Wei Z.-L., Yang H., Zhou F., Schwarz P., Gawell L., Gagnon H., Pelcman B., Schmidt R., Yi Yue S.Y., Walpole C., Brown W., Zhou E., Labarre M., Payza K., St-Onge S., Kamassah A., Morin P.-E., Projean D., Ducharme J., and Roberts E. J. Med. Chem. 43 (2000) 3878 Additional examples are found in Refs. 1,2
-
(2000)
J. Med. Chem.
, vol.43
, pp. 3878
-
-
Plobeck, N.1
Delorme, D.2
Wei, Z.-L.3
Yang, H.4
Zhou, F.5
Schwarz, P.6
Gawell, L.7
Gagnon, H.8
Pelcman, B.9
Schmidt, R.10
Yi Yue, S.Y.11
Walpole, C.12
Brown, W.13
Zhou, E.14
Labarre, M.15
Payza, K.16
St-Onge, S.17
Kamassah, A.18
Morin, P.-E.19
Projean, D.20
Ducharme, J.21
Roberts, E.22
more..
-
8
-
-
0242330268
-
-
For a recent use of a Doebner-Miller variant, see:
-
For a recent use of a Doebner-Miller variant, see:. Cho C.K., Lee N.Y., Choi H.-J., Kim T.-J., and Shim S.C. J. Heterocycl. Chem. 40 (2003) 929
-
(2003)
J. Heterocycl. Chem.
, vol.40
, pp. 929
-
-
Cho, C.K.1
Lee, N.Y.2
Choi, H.-J.3
Kim, T.-J.4
Shim, S.C.5
-
9
-
-
33344479261
-
-
For an exception, in the preparation of 7-hydroxyquinoline, see:
-
For an exception, in the preparation of 7-hydroxyquinoline, see:. Cameron M., Hoerrner R.S., McNamara J.M., Figus M., and Thomas S. Org. Proc. Res. Dev. 10 (2006) 149
-
(2006)
Org. Proc. Res. Dev.
, vol.10
, pp. 149
-
-
Cameron, M.1
Hoerrner, R.S.2
McNamara, J.M.3
Figus, M.4
Thomas, S.5
-
10
-
-
33646058040
-
-
For a limited set of recent examples, see:
-
For a limited set of recent examples, see:. Movassaghi M., and Hill M.D. J. Am. Chem. Soc. 128 (2006) 4592
-
(2006)
J. Am. Chem. Soc.
, vol.128
, pp. 4592
-
-
Movassaghi, M.1
Hill, M.D.2
-
13
-
-
33845962586
-
-
The only known example of this strategy for the synthesis of mono-7-substituted quinolines used 7-bromoquinoline, as documented in Ref. 2a. For application to more highly substituted 7-halo- and 7-trifloxyquinolines, see:
-
The only known example of this strategy for the synthesis of mono-7-substituted quinolines used 7-bromoquinoline, as documented in Ref. 2a. For application to more highly substituted 7-halo- and 7-trifloxyquinolines, see:. Boschelli D.H., Wu B., Ye F., Wang Y., Golas J.M., Lucas J., and Boschelli F. J. Med. Chem. 49 (2006) 7868
-
(2006)
J. Med. Chem.
, vol.49
, pp. 7868
-
-
Boschelli, D.H.1
Wu, B.2
Ye, F.3
Wang, Y.4
Golas, J.M.5
Lucas, J.6
Boschelli, F.7
-
14
-
-
14644413418
-
-
Barrios Sosa A.C., Boschelli D.H., Wu B., Wang Y., and Golas J.M. Bioorg. Med. Chem. Lett. 15 (2005) 1743
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 1743
-
-
Barrios Sosa, A.C.1
Boschelli, D.H.2
Wu, B.3
Wang, Y.4
Golas, J.M.5
-
15
-
-
33745116626
-
-
Wu B., Barrios Sosa A.C., Boschelli D.H., Boschelli F., Honores E.E., Golas J.M., Powell D.W., and Wang Y.D. Bioorg. Med. Chem. Lett. 16 (2006) 3993
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 3993
-
-
Wu, B.1
Barrios Sosa, A.C.2
Boschelli, D.H.3
Boschelli, F.4
Honores, E.E.5
Golas, J.M.6
Powell, D.W.7
Wang, Y.D.8
-
16
-
-
0037152464
-
-
Berger D., Dutia M., Powell D., Wissner A., DeMorin F., Raifeld Y., Weber J., and Boschelli F. Bioorg. Med. Chem. Lett. 12 (2002) 2989
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 2989
-
-
Berger, D.1
Dutia, M.2
Powell, D.3
Wissner, A.4
DeMorin, F.5
Raifeld, Y.6
Weber, J.7
Boschelli, F.8
-
19
-
-
34447340637
-
-
Milbank J.B.J., Knauer C.S., Augelli-Szafran C.E., Sakkab-Tan A.T., Lin K.K., Yamagata K., Hoffman J.K., Zhuang N., Thomas J., Galatsis P., Wendt J.A., Mickelson J.W., Schwarz R.D., Kin ora J.J., Lotarski S.M., Stakich K., Gillespie K.K., Lam W.W., and Mutlib A.E. Bioorg. Med. Chem. Lett. 17 (2007) 4415
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 4415
-
-
Milbank, J.B.J.1
Knauer, C.S.2
Augelli-Szafran, C.E.3
Sakkab-Tan, A.T.4
Lin, K.K.5
Yamagata, K.6
Hoffman, J.K.7
Zhuang, N.8
Thomas, J.9
Galatsis, P.10
Wendt, J.A.11
Mickelson, J.W.12
Schwarz, R.D.13
Kin ora, J.J.14
Lotarski, S.M.15
Stakich, K.16
Gillespie, K.K.17
Lam, W.W.18
Mutlib, A.E.19
-
20
-
-
0142092193
-
-
Maerten E., Hassouna F., Couve-Bonnaire S., Mortreux A., Carpentier J.-F., and Castanet Y. Synlett (2003) 1874
-
(2003)
Synlett
, pp. 1874
-
-
Maerten, E.1
Hassouna, F.2
Couve-Bonnaire, S.3
Mortreux, A.4
Carpentier, J.-F.5
Castanet, Y.6
-
21
-
-
0033531994
-
-
Najiba D., Carpentier J.-F., Castanet Y., Biot C., Brocard J., and Mortreux A. Tetrahedron Lett. 40 (1999) 3719
-
(1999)
Tetrahedron Lett.
, vol.40
, pp. 3719
-
-
Najiba, D.1
Carpentier, J.-F.2
Castanet, Y.3
Biot, C.4
Brocard, J.5
Mortreux, A.6
-
22
-
-
67650030342
-
-
note
-
The ratio of 4:5 was determined using HPLC by comparison of the area under the curve for each compound in the reaction mixture. This ratio was then corrected with the extinction coefficient of each component as determined from independently prepared samples of known concentration. Conversion values were calculated as the ratio of (4+5):3, with correction by the extinction coefficient as above.
-
-
-
-
23
-
-
67650018720
-
-
note
-
7ClN calc'd [M+H] = 164.0267, found 164.0300.
-
-
-
-
24
-
-
67650056074
-
-
note
-
2 + ligands, including numerous triarylphosphines, SPhos and XPhos. Although Pd(0) complexes were active catalysts (entries 1-4), we focused on P(II) species due to their relative ease of handling in air.
-
-
-
-
25
-
-
67650036545
-
-
note
-
3SiCl byproduct of the reduction creates acidic conditions for any adventitious water. For relevant observations see: (a) Illuminati, G.; Gilman, H. J. Am. Chem. Soc. 1950, 72, 4288 and (b) Cutler, R.A..; Surrey, A.. J. Am. Chem. Soc. 1950, 72, 3394.
-
-
-
-
26
-
-
67650010976
-
-
note
-
2 = 8.4 Hz, 1H), 7.24-7.17 (m, 2H).
-
-
-
-
29
-
-
67650059129
-
-
note
-
2 = 7.4 Hz, 2H), 1.37 (s, 9H).
-
-
-
-
30
-
-
67650048128
-
-
note
-
3) δ 152.3, 147.1, 136.0, 135.5, 130.3, 129.3, 127.3, 123.6, 118.4, 113.0.
-
-
-
-
31
-
-
67650008629
-
-
note
-
2 = 10.0 Hz, 1H), 4.29-4.20 (m, 1H), 3.81 (br s, 1H), 1.65-1.51 (m, 2H), 1.42-1.30 (m, 2H), 0.92 (t, J = 7.0 Hz, 3H).
-
-
-
-
32
-
-
67650048129
-
-
note
-
2 = 8.6 Hz, 1H), 7.30 (d, J = 8.6 Hz, 1H), 2.79 (t, J = 8.1 Hz, 2H), 1.84-1.77 (m, 2H), 1.49-1.41 (m, 2H), 0.98 (t, J = 7.4 Hz, 3H).
-
-
-
-
33
-
-
67650051313
-
-
note
-
Interestingly, iPrMgCl was unreactive under these conditions. PhMgCl underwent a similar 1,2-addition as described in Eq. 3.
-
-
-
-
34
-
-
67650059128
-
-
note
-
3) δ 8.12 (d, J = 8.7 Hz, 1H), 7.85 (d, J = 8.4 Hz, 1H), 7.78-7.67 (m, 4H), 7.23-7.16 (m, 2H), 5.97-5.94 (m, 1H), 5.54-5.50 (m, 1H), 2.41-2.38 (m, 3H).
-
-
-
|